Aldosterone activates Na+/H+ exchange in vascular smooth muscle cells by nongenomic and genomic mechanisms  by Ebata, Satoru et al.
Kidney International, Vol. 56 (1999), pp. 1400–1412
Aldosterone activates Na1/H1 exchange in vascular smooth
muscle cells by nongenomic and genomic mechanisms
SATORU EBATA, SHIGEAKI MUTO, KOJI OKADA, JUN NEMOTO, MORIMASA AMEMIYA,
TOSHIKAZU SAITO, and YASUSHI ASANO
Departments of Nephrology and Endocrinology & Metabolism, Jichi Medical School, Minamikawachi, Tochigi, Japan
occurs through both MR and GR and requires gene transcrip-Aldosterone activates Na1/H1 exchange by nongenomic and
tion and protein synthesis. Both short- and long-term effectsgenomic mechanisms in vascular smooth muscle cells.
of ALDO are mediated through PKC activation. Therefore,Background. In vascular smooth muscle cells (VSMCs),
ALDO activates NHE by nongenomic and genomic mecha-Na1/H1 exchange (NHE) plays an important role in intracellu-
nisms in VSMCs.lar pH (pHi) regulation. Recently, nongenomic effect of aldo-
sterone (ALDO) on NHE activity has been suggested in
VSMCs. However, the nongenomic and genomic effects of
ALDO on NHE and the intracellular signaling mechanisms
Na1/H1 exchange (NHE) is a plasma membrane trans-for these effects have not fully been determined in VSMCs.
port protein found in a broad range of biological systems,Methods. The effects of short- (3 hr) and long- (24 hr) term
exposure to ALDO on NHE activity were examined in cultured including vascular smooth muscle cells (VSMCs) [1, 2].
VSMCs from rat thoracic aortae by using single-cell pHi mea- In VSMCs, entry of Na1 into cells in exchange for an
surement with the pH-sensitive dye 2979-bis(carboxyethyl)-
intracellular H1 is the main effect of NHE, which there-5(6)-carboxyfluorescein. The NHE activity was calculated from
fore is involved in control of intracellular pH (pHi), cellthe initial rate of Na1-dependent pHi recovery after acid load.
Results. The NHE activity significantly increased after short- volume regulation, and initiation of cell growth and pro-
and long-term exposure of VSMCs to ALDO (1026 m). The liferation [3–5].
inhibitors of gene transcription (actinomycin D) and of protein Recently, the rapid effect (within 15 min) of aldoste-
synthesis (cycloheximide) had no effect on the short-term
rone (ALDO) on NHE activity has been demonstratedALDO effect, but inhibited the long-term ALDO effect. The
in human mononuclear leukocytes [6] and Madin-Darbyantagonists of the mineralocorticoid receptor (MR) (spirono-
lactone) and of the glucocorticoid receptor (GR) (RU38486) canine kidney (MDCK) cells [7]. In these cells, NHE
caused no effect on the short-term ALDO effect, but inhibited activation is still evident by the presence of inhibitors of
the long-term ALDO effect. Two protein kinase C (PKC) protein synthesis, and is insensitive to the mineralocorti-inhibitors (staurosporine A and calphostin C) and PKC down-
coid receptor antagonist, spironolactone [6, 7], and is thusregulation (24 hr pre-exposure to phobol 12-myristate 13-ace-
tate, PMA) inhibited both the short- and long-term ALDO mediated through nongenomic mechanism(s). These spi-
effects. Exposure of VSMCs to PMA for 3 hours mimicked ronolactone-insensitive events seem to be mediated via
the short-term effect of ALDO on NHE activity. ALDO sig- a high affinity, membrane-bound, aldosterone receptor
nificantly increased PKC activity in VSMCs. The short-term
[6]. The rapid stimulatory effect of ALDO on NHEALDO effect was inhibited by disruptors of microtubule (col-
activity has also been demonstrated in VSMCs [8, 9].chicine) and of filamentous-actin (cytochalasin B). Long-term
exposure of ALDO caused a threefold increase in NHE (NHE-1) However, it is unclear in VSMCs whether the rapid
mRNA levels. ALDO effect is mediated through a nongenomic mecha-
Conclusions. The short-term effect of ALDO on NHE activ- nism, since it has not yet been demonstrated whether ority is not mediated through either MR or GR, occurs indepen-
not the rapid ALDO effect is influenced by inhibitorsdent of gene transcription and protein synthesis, and occurs
of transcription and of translation. A variety of secondthrough a mechanism involving the structural elements of cy-
toskeleton. The long-term effect of ALDO on NHE activity messengers have been reported as potential mediators
for the rapid effect of ALDO on NHE activity in VSMCs,
including increased intracellular inositol 1,4,5-trisphos-Key words: VSMC, nongenomic effect, genomic effect, intracellular
signaling, hypertension. phate (IP3) formation [8, 10], increased diacylglycerol
(DAG) production [10], phospholipase C (PLC) activa-Received for publication October 20, 1998
tion [8], rapid increase in free intracellualr Ca21 concen-and in revised form April 14, 1999
Accepted for publication May 19, 1999 tration ([Ca21]i) [11, 12], and protein kinase C (PKC) a
isoform translocation from cytosol to plasma membrane 1999 by the International Society of Nephrology
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[10]. However, the intracellular signaling mechanisms carboxyfluorescein acetoxymethyl ester (BCECF-AM)
by a modification of the methods described by Berk etfor the rapid effect of ALDO on NHE activity are not
fully understood in VSMCs. It has not yet been estab- al [18, 19]. Prior to each experiment, the cells grown to
confluence were incubated for 30 minutes in FBS-freelished whether PKC activation is actually responsible for
the rapid ALDO effect on NHE activity in VSMCs. In MEM containing BCECF-AM (2 mm) at 378C. The Petri
dish was then placed on the stage of an inverted epiflu-addition, it is not known whether the PKC a isoform
translocation from cytosol to plasma membrane actually orescence microscope (IMT-2, Olympus, Tokyo, Japan),
and were then continuously perfused with Hepes-buf-corresponds to activation of PKC. Little is known about
the involvement of the cytoskeleton in the rapid ALDO fered solutions (described later in this article) by gravity.
A water jacket was used to maintain temperature in theeffect, although recent studies have demonstrated that
the interaction between the cytoskeleton and plasma dish at 378C.
Single-cell measurement of pHi was performed usingmembrane regulates NHE activity in osteoblast-like rat
cell lines (RCJ 1.20) exposed to hyperosmotic stress [13], a microscopic fluorometer (OSP-3; Olympus, Tokyo, Ja-
pan) as described previously [20]. Measurements wererabbit proximal tubule cells treated with angiotensin II
[14], and Caco-2 cells (human colon carcinoma cell line) made at 3100 magnification, and the diameter of the
beam of light focused on the single VSMC was approxi-under serum-deprivation [15].
In contrast to the nongenomic effect, the classical ge- mately 7.5 mm. The light source was a 75-W xenon lamp.
The fluorescent dye was excited alternatively at 440 andnomic effect of ALDO involves binding to intracellular
receptors, transcription, translation, and protein synthe- 490 nm by spinning the sector mirror at 300 revolutions/
min and measured at a wavelength of 530 nm. Becausesis. Thus, the ALDO-induced response following geno-
mic activation should be preceded by a latent period in in this apparatus it takes 10 milliseconds to obtain one
fluorescence ratio (I490/I440), the single VSMC was ex-the range of hours. However, it has not yet been estab-
lished whether ALDO genomically regulates NHE in posed to light for 1 second to obtain one mean I490/I440.
We used only VSMCs that had at least 20-fold greaterVSMCs. Furthermore, little is known about the mecha-
nism(s) for the genomic effect of ALDO on NHE activity fluorescence intensity than that of the background. Cali-
bration of the BCECF excitation ratio for each experi-in VSMCs. Therefore, the present study was conducted
to determine whether there are nongenomic and geno- ment was determined using the K1/nigericin technique
as described previously [21].mic effects of ALDO on NHE activity in VSMCs and
to determine the intracellular signaling mechanisms for The NHE activity of VSMCs was assayed as the initial
rate of Na1-dependent pHi increase (dpHi/dt) after acidthe nongenomic and genomic ALDO effects.
load using nigericin, a K1/H1 ionophore, in the absence
of CO2/HCO32 [22, 23]. The composition of solutionsMETHODS
used for the assay was as follows: (a) for the Hepes-
Culture of rat vascular smooth muscle cells buffered Na1 solution, 130 mm NaCl, 5 mm KCl, 1.5 mm
MgCl2, 1 mm CaCl2, and 30 mm Hepes; and (b) for thePrimary cultures of rat VSMCs were isolated from
thoracic aortae of male Sprague-Dawley rats (200 to Na1-free solution, Na1 was isosmotically replaced with
N-methyl-d-glucamine (NMDG). The nigericin-contain-250 g) by treatment with collagenase, as described pre-
viously in our laboratory [16, 17]. Briefly, the cells were ing solution was the Na1-free solution (b) treated with
10 mm nigericin. All solutions were adjusted to pH 7.4cultured in Eagle’s minimal essential medium (MEM)
supplemented with 10% fetal bovine serum (FBS), 26.1 at 378C. Once a stable fluorescence signal was reached,
Na1 was removed by replacing NMDG. With the re-mm NaHCO3, 100 U/ml penicillin, and 100 mg/ml strepto-
mycin in a 5% CO2 incubator at 378C. After reaching moval of Na1, the pHi decreased, and when Na1 was re-
added there was rapid recovery of pHi to baseline levels.confluence, VSMCs were passaged through trypsin/
EDTA and seeded at a 1 : 3 ratio in 100-mm culture The dpHi/dt at pHi of 6.1 was calculated from a line
drawn tangential to the initial 30 second deflection afterdishes (Becton Dickinson, NJ, USA). Experiments were
performed with VSMCs which were grown to confluence the return of Na1 to the perfusate.
Intracellular buffering capacity was determined fromafter 4 to 10 passages.
the pHi response to the removal of NH3/NH41 using the
Measurements of pHi in VSMCs following formula: intracellular buffering capacity (bI) 5
D[NH41]i/DpHi, where [NH41]i is the intracellular con-For pHi measurements, cells were plated on 35-mm
Petri dishes containing a glass coverslip bottom (MatTec, centration just before NH3/NH41 removal, calculated as
[NH41]i 5 [NH41]o 3 10(7.4–pHi); and DpHi is the pHi changeAshland, MA, USA), and were used two to seven days
later. Cells were incubated in FBS-free MEM for 48 on removal of NH41 [24]. In the present study, bI was
calculated at pHi of 6.1. A change in dpHi/dt is interpre-hours before use. The pHi was continuously measured
using the pH-sensitive dye 2979-bis(carboxyethyl)-5(6)- ted to reflect a difference in NHE activity when the
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intracellular buffering capacities in two conditions are minutes at 688C before hybridization using Quick-Hybe
(Stratagene, La Jolla, CA, USA), then hybridized forsimilar.
one hour at 688C in the same solution with 106 cpm/ml of
Measurement of PKC activity [a-32P]-dCTP random primer-labeled probes. The NHE
probe was a Pst I-Pst I fragment (nucleotides 478–1850)We measured PKC activity in ALDO-treated VSMCs
using the previously described methods [25]. VSMCs of the rat NHE-1 cDNA (a generous gift from Dr. John
Orlowski, McGill University, Montreal, Canada) [27].were cultured and grown in 35-mm culture dishes (Bec-
ton Dickinson, NJ, USA). Confluent VSMCs were The filters were then washed twice for 10 minutes at
room temperature in 2 3 SSC and 0.1% SDS followedplaced in serum-free MEM for 48 hours, and were then
exposed to ALDO (1026 m) for the next 24 hours. The by a 10-minute wash at 458C in 0.1 3 SSC and 0.1%
SDS. Autoradiography was performed at 2708C andreaction was then stopped by the addition of 100 ml of
extraction solution (20 mm Tris/HCl, 0.5 mm EDTA, 0.5 quantitated by densitometric scanning (Image Analyzer
TIF-64; Immunomedica, Tokyo, Japan). The filter mem-mm EGTA, 0.5% Triton X-100, 25 mg/ml aprotinin, and
leupeptin, pH 7.5). Cell extracts were centrifuged at 1500 branes were also hybridized with [a-32P]-dCTP-labeled
rat glyceraldehyde-3-phosphate dehydrogenase (GAP-g for five minutes. The supernatant was then incubated
with 25 mm of a synthetic peptide [amino acids of bovine DH) probe. The NHE-1 mRNA area was standardized
for each lane in the GAPDH area to control for variabil-myelin basic protein (MBP4-14; Sigma Chemical Co.)] [26]
and reaction mixture containing 20 mm Tris/HCl (pH ity in RNA loading.
7.5), 5 mm Mg acetate, 0.1 mm CaCl2, 0.5 mg phosphatidyl
Materialsserine, 50 ng diolein, and 50 mm [g-32P]ATP (specific
activity, 10 Ci/mm; New England Nuclear, Boston, MA, All chemicals were obtained from Sigma Chemical
Co. (St. Louis, MO, USA) unless noted as follows: MEM,USA) for 10 minutes at 308C. The reaction products
were placed on P-81 paper (Whatman International Ltd, penicillin, streptomycin, and FBS were from Flow Labo-
ratories (Irvine, Scotland, UK); ethylisopropylamilorideClifton, NJ, USA) and were washed three times with 20
ml of ice-cold 10% phosphoric acid. The radioactivity (EIPA) was from Research Biochemicals Incorporated
(Natick, MA, USA), [a-32P]-dCTP was from Amersham,was counted by a liquid scintillation counter (Aloka
LSC-671, Tokyo, Japan). Specific radioactivity was ob- [g-32P]ATP was from New England Nuclear (Boston,
MA, USA), Hepes was from Dojindo (Kumamoto, Ja-tained by subtracting the radioactivity of the synthetic
peptide-free reaction from the synthetic peptide-directed pan); and BCECF-AM was from Molecular Probes Inc.
(Eugene, OR, USA). RU38486 was a generous gift fromradioactivity. PKC activity was represented as pm of ATP
incorporated per mg protein of cell extracts for one mi- Roussel Uclaf (Romainville, France).
nute. The protein content of the cells was determined
Statistical analysisby the Bio-Rad protein assay kit (Bio-Rad Laboratories
Inc., Richmond, CA, USA), using bovine serum albumin Results are expressed as mean 6 sem. Comparisons
were performed by nonpaired Student’s t-test and one-(BSA) as the standard.
way analysis of variance in combination with Fisher’s
RNA isolation and Northern blot analysis protected least significant difference, as needed. P values
of ,0.05 were considered significant.Vascular smooth muscle cells were cultured and grown
in 100-mm culture dishes (Becton Dickinson). Confluent
VSMCs were placed in serum-free MEM for 48 hours,
RESULTS
and were then exposed to ALDO (1026 m) for the next
Effect of aldosterone on pHi in VSMCs24 hours. Thereafter, total RNA was isolated using a
single-step guanidine thiocyanate method as reported We first examined the effect of ALDO on baseline
pHi in VSMCs. VSMCs were then placed in serum-freepreviously [16, 17]. In brief, VSMCs were lyzed using
ISOGENe (Nippon Gene, Tokyo, Japan), which con- MEM for 48 hours before the addition of the hormone,
and then exposed to ALDO (1026 m) for 3 hours (short-tained phenol and guanidine isothiocyanate. The lysate
was extracted with chloroform/isopropanol, and washed term exposure) or 24 hours (long-term exposure). Re-
sults are illustrated in Figure 1. After short-term expo-with 75% ethanol. Poly (A)1 RNA was purified using
oligo(dT)-latex column (Takara, Tokyo, Japan). Equal sure of VSMCs to ALDO, the baseline pHi (7.19 6 0.03,
N 5 13, P , 0.01) was significantly higher than that inamounts of Poly (A)1 RNA (5 mg/lane) were size-frac-
tionated on 1% denaturing agarose-formaldehyde gels cells exposed to control MEM (7.03 6 0.04, N 5 13).
Similarly, the pHi after long-term exposure of VSMCsand capillary blotted onto nylon membrane filters (Hy-
bond N, Amersham) in 20 3 standard saline citrate (SSC; to ALDO (7.17 6 0.03, N 5 13, P , 0.05) was signifi-
cantly higher than in cells exposed to control MEM1 3 SSC contains 0.15 m NaCl and 0.0015 m sodium
citrate, pH 7.0). The filters were prehybridized for 30 (7.06 6 0.02, N 5 13).
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the NHE activity was stimulated in VSMCs treated with
ALDO for 3 and 24 hours. We next examined the time-
dependent alteration in the NHE activity induced by
ALDO (1026 m), as shown in Figure 3. Upon the addition
of ALDO to VSMCs, the dpHi/dt after acid load rapidly
increased to 1.5 times the control by as early as 3 hours.
The ALDO-induced increase in dpHi/dt was sustained
with continued exposure of VSMCs to ALDO for up to
24 hours, with a maximum 2.0-fold increase at 12 hours.
Dose-dependent effect of aldosterone on NHE activity
We next examined the dose-dependent effects of
ALDO on NHE activity. VSMCs were placed in serum-
free MEM for 48 hours, and were then exposed to ALDO
for 12 hours at various concentrations. As shown in Fig-
ure 4, the ALDO-induced increase in NHE activity was
Fig. 1. Effects of aldosterone (ALDO; 1026 M) on baseline intracellular
dose-dependent: significant effects of ALDO on NHEpH (pHi) in vascular smooth muscle cells (VSMCs). VSMCs were ex-
posed to control Eagle’s minimal essential medium (MEM) or ALDO- activity were observed at 1028 to 1026 m. In rats, plasma
supplemented MEM for 3 (A) or 24 hours (B) before the measurement concentration of ALDO is in the range of 10210 to 1028 m
of pHi. Data are expressed as means 6 se. *P , 0.01, **P , 0.05 [28]. Therefore, ALDO at physiological concentrationscompared to control. N is the number of experiments.
directly activates the NHE. In the following experiments,
we focused on the mechanisms for the short- (3 hr) and
long-term (24 hr) effects of ALDO on NHE activity.
Effect of aldosterone on NHE activity
Effects of actinomycin D and cycloheximide onSince the NHE is an important mechanism for the
aldosterone-induced increase in NHE activitymaintenance and regulation of pHi in VSMCs [4], we
next examined whether the ALDO-induced intracellular To determine whether gene transcription and protein
synthesis are required for the ALDO-induced increasealkalinization was due to the activation of the NHE.
Typical tracings of pHi in cells treated with control MEM in NHE activity, VSMCs were incubated with actinomy-
cin D (ACD), an inhibitor of gene transcription, or cyclo-or ALDO-supplemented MEM for three hours are de-
picted in Figure 2. Cells were first bathed in the Hepes- heximide (CHX), an inhibitor of protein synthesis. For
these experiments, VSMCs were placed in serum-freebuffered Na1 solution (130 mm Na). The solution was
then changed to the Na1-free solution (0 mm Na) con- MEM for 48 hours, and were then exposed to MEM
treated with ACD (4 mg/ml) or CHX (20 mg/ml) plustaining 10 mm nigericin for four minutes, which caused
pHi to decrease to ~5.9 to 6.1. Nigericin was then re- ALDO (1026 m) for 3 or 24 hours. This concentration
of CHX (20 mg/ml) inhibited protein synthesis by 95%moved by resuspending the Na1-free solution containing
1% (wt/vol) BSA (which binds the ionophore) for two as determined by [3H]leucine incorporation [16]. Results
are shown in Figure 5A for ACD-treated VSMCs andminutes. Cells were then bathed in the Na1-free solution
for one minute. Thereafter, subsequent addition of Na1 Figure 5B for CHX-treated VSMCs. ACD or CHX alone
had no effect on NHE activity. Neither ACD nor CHXto the extracellular solution caused a rapid increase in
pHi, the rise being more rapid in VSMCs exposed to influenced the short-term stimulatory effect of ALDO on
NHE activity, whereas both of them completely inhibitedALDO-supplemented MEM than to control MEM (Fig.
2). Similar results were obtained in VSMCs treated with the long-term stimulatory effect of ALDO on NHE ac-
tivity.ALDO-supplemented MEM for 24 hours. The Na1-
dependent pHi recoveries after the acid load in cells
Effects of spironolactone and RU38486 ontreated with both control MEM and with ALDO-supple-
aldosterone-induced increase in NHE activitymented MEM were completely inhibited by 100 mm
EIPA, a specific NHE inhibitor (Fig. 2). On the other To examine whether or not the stimulatory effects
of ALDO on NHE activity occur via mineralocorticoidhand, there were no significant differences of intrinsic
buffering capacity at pHi of 6.1 between the two condi- receptor (MR) and/or glucocorticoid receptor (GR),
VSMCs were placed in serum-free MEM for 48 hours,tions (3 hr, control 19.7 6 1.0 mm/H1 · pH, N 5 7,
ALDO, 19.2 6 1.2 mm/H1 · pH, N 5 7; 24 hr, control, and were then exposed to the MR antagonist spironolac-
tone (SPR; 1024 m) or the GR antagonist RU38486 (RU;18.8 6 1.1 mm/H1 · pH, N 5 7, ALDO, 19.2 6 1.1 mm/H1·
pH, N 5 7). Therefore, the Na1-dependent pHi recovery 1025 m), plus ALDO (1026 m) for 3 or 24 hours. Results
are shown in Figure 6A for SPR-treated VSMCs andafter acid load was dependent on the NHE activity, and
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Fig. 2. Typical tracing showing Na1-depen-
dent pHi recovery in VSMC exposed to
ALDO (1026 M) for 3 hours, in the absence or
presence of 100 mM ethylisopropylamiloride
(EIPA). Symbols are: (d) ALDO; (s) con-
trol; (j) ALDO 1 EIPA; (h) control 1
EIPA.
Fig. 3. Time course of Na1/H1 exchange (NHE) activity induced by
ALDO in VSMCs. VSMCs were exposed to control MEM or ALDO-
supplemented MEM for various terms before the measurement of
Fig. 4. Dose-dependent effects of ALDO on NHE activity in VSMCs.dpHi/dt after a nigericin-induced intracellular acidosis. Data are ex-
VSMCs were exposed to ALDO (1026 m) for 12 hours at various concen-pressed as the percentage of dpHi/dt compared with control values at
trations. Data are expressed as the percentage of dpHi/dt comparedeach term, each point is means 6 se of 6 to 12 separate experiments.
with those observed in VSMCs exposed to MEM (control), each pointdpHi/dt 5 initial rate of Na1-dependent pHi recovery. *P , 0.001,
is means 6 se of 6 separate experiments. *P , 0.05, **P , 0.01 compared**P , 0.0001 compared to control.
to control value.
Figure 6B for RU-treated VSMCs. SPR or RU alone
48 hours, and were then exposed to the MEM treatedcaused no effect on NHE activity. The addition of SPR or
with one of two PKC inhibitors, staurosporine A (ST;RU to VSMCs did not affect the short-term stimulatory
1027 m) or calphostin C (CAL; 5 3 1027 m) plus ALDOeffect of ALDO on NHE activity, whereas both of them
(1026 m) for 3 or 24 hours. Results are shown in Figure 7Acompletely inhibited the long-term stimulatory effect of
for ST-treated VSMCs and Figure 7B for CAL-treatedALDO on NHE activity.
VSMCs. ST or CAL alone had no effect on NHE. On
Role of protein kinase C activation in mediating the other hand, ST completelty inhibited both the short-
aldosterone-induced increase in NHE activity term and long-term stimulatory effects of ALDO on
NHE activity. Similarly, CAL completely inhibited bothProtein kinase C has been shown to play an important
the short-term and long-term stimulatory effects ofrole in the regulation of NHE activity in many tissues
ALDO on NHE activity. The role of PKC was further[1, 29], including VSMCs [19, 30–32]. Therefore, we ex-
examined in PKC-depleted cells. For this experiment,amined whether PKC activation is responsible for the
VSMCs were placed in serum-free MEM for 48 hours,ALDO-induced increase in NHE activity. For this pur-
pose, VSMCs were placed in serum-free MEM for and were then pre-exposed to phorbol 12-myristate 13-
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Fig. 5. Effects of the inhibitors of gene tran-
scription, actinomycin D (ACD), or protein
synthesis, cycloheximide (CHX) on ALDO-
induced increase in NHE activity in VSMCs.
(A) VSMCs were exposed to control MEM
or ALDO (1026 m)-supplemented MEM for
3 or 24 hours, in the absence or presence of
ACD (4 mg/ml). (B) VSMCs were exposed to
control MEM or ALDO (1026 m)-supple-
mented MEM for 3 or 24 hours, in the absence
or presence of CHX (20 mg/ml). Data are ex-
pressed as the percentage of dpHi/dt compared
with those observed in ALDO-untreated
VSMCs without ACD or CHX (control). The
number of experiments done on ACD- or
CHX-treated VSMCs is 6.
Fig. 6. Effects of the mineralocorticoid re-
ceptor (MR) antagonist spironolactone (SPR)
or the glucocorticoid receptor (GR) antago-
nist RU 38486 (RU) on ALDO-induced in-
crease in NHE activity in VSMCs. (A) VSMCs
were exposed to control MEM or ALDO
(1026 m)-supplemented MEM for 3 or 24
hours, in the absence or presence of SPR
(1024 m). (B) VSMCs were exposed to control
MEM or ALDO (1026 m)-supplemented
MEM for 3 or 24 hours, in the absence or
presence of RU (1025 m). Data are expressed
as the percentage of dpHi/dt compared with
those observed in ALDO-untreated VSMCs
without SPR or RU (control). The number
of experiments done on SPR- or RU-treated
VSMCs is 6 and 8, respectively.
acetate (PMA; 1027 m) for 24 hours. This treatment has PKC) for 3 hours actually increases NHE activity. As
shown in Figure 7D, treatment of VSMCs with PMAbeen reported to down-regulate PKC activity in cultured
VSMCs [33]. The VSMCs were then exposed to either (1027 m) for 3 hours caused NHE activity to increase to
1.5 times the control level. We next examined whethercontrol MEM or ALDO-supplemented MEM for 3 or
24 hours in the presence of PMA. Results are shown in ALDO actually increases PKC activity in VSMCs. Expo-
sure of VSMCs to ALDO (1026 m) time-dependentlyFigure 7C. Pre-exposure of VSMCs to PMA alone had no
effect on NHE activity; however, it completely inhibited activated PKC: a maximal response occurred at five min-
utes (Fig. 8). This ALDO-induced PKC activation wasboth short- and long-term stimulatory effects of ALDO
on NHE activity. We next examined whether or not not sustained and down-regulated with time, so that after
60 minutes of continuous exposure to ALDO, PKC activ-exposure of VSMCs to PMA (a specific activator of
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CYTO completely inhibited the short-term stimulatory
effect of ALDO on NHE activity. These findings suggest
that the structural elements of cytoskeleton are involved
in the short-term ALDO-induced activation of NHE.
Long-term effect of aldosterone on NHE mRNA
levels in VSMCs
The above experiments suggest that transcription and
translation are involved in the long-term stimulatory effect
of ALDO on NHE activity. Therefore, we finally exam-
ined the long-term effect of ALDO on NHE (NHE-1)
mRNA levels in VSMCs. Representative Northern blots
are shown in Figure 10. The NHE-1 cDNA probe hybrid-
ized to a single band of 4.8 to 5.0 kb, as previously
described for NHE-1 mRNA in cultured VSMCs [35].
Fig. 8. Effects of ALDO on PKC activity in VSMCs. VSMCs were When VSMCs were exposed to ALDO (1026 m) for 24
exposed to ALDO (1026 m) for various terms before the assay of PKC hours, NHE-1 mRNA levels increased to 3.0 times theactivity. Each point is means 6 se of 6 separate experiments. *P ,
control level. There was no significant difference in0.05, **P , 0.001 compared with the value at time 0.
GAPDH mRNA levels between the control and ALDO-
treated VSMCs.
ity in VSMCs returned to control levels. Such a transient
increase in PKC activity has also been reported in angio- DISCUSSION
tensin II- and arginine vasopressin-treated VSMCs [33].
The present study was designed to determine whetherTaken together, these findings indicate that both short-
there are nongenomic and genomic effects of ALDO onand long-term stimulatory effects of ALDO on NHE
NHE activity in VSMCs and to determine the mechan-activity occur via PKC activation.
isms whereby ALDO regulates NHE activity in VSMCs.
Our data demonstrate that ALDO increases VSMCRole of cytoskeletal elements in aldosterone-induced
NHE activity as early as 3 hours and that this effectincrease in NHE activity
is sustained for up to 24 hours. The ALDO-mediatedRecent studies demonstrate that the interaction be-
increase in NHE activity is dose-dependent. Short-termtween the cytoskeleton and the plasma membrane regu-
(3 hr) effect of ALDO on NHE activity is not mediatedlates the activity of many ion channels and transport
through either MR or GR, occurs independently of geneproteins, including the NHE [13–15, 34]. To determine
transcription and protein synthesis, and occurs via awhether the cytoskeleton is involved in the short-term
mechanism involving the cytoskeletal elements. In sharpeffect of ALDO on NHE activity, VSMCs were incu-
contrast, long-term (24 hr) effects of ALDO on NHEbated with colchicine (COL), a disruptor of microtubules,
activity occur through both MR and GR and requireor cytochalasin B (CYTO), a disruptor of filamentous
gene transcription and protein synthesis. Therefore, theactin (F-actin). For this purpose, VSMCs were placed in
short- and long-term effects of ALDO on NHE activityserum-free MEM for 48 hours, and were then exposed
are differentially regulated. However, ALDO transientlyto MEM treated with either COL (1024 m) or CYTO
activates PKC, and PKC activation contributes to both(1024 m), plus ALDO (1026 m) for 3 hours. Results are
short- and long-term stimulatory effects of ALDO onshown in Figure 9. COL or CYTO alone had no influence
on NHE activity. On the other hand, both COL and NHE activity.
b
Fig. 7. Effects of PKC inhibitors or PKC down-regulation on ALDO-induced increase in NHE activity in VSMCs. (A) VSMCs were exposed to
control MEM or ALDO (1026 m)-supplemented MEM for 3 or 24 hours, in the absence or presence of staurosporine A (ST). Data are expressed
as the percentage of dpHi/dt compared with those observed in ALDO-untreated VSMCs without ST (control). The number of experiments done
on ST–treated VSMCs is 8. (B) VSMCs were exposed to control MEM or ALDO (1026 m)-supplemented MEM for 3 or 24 hours, in the absence
or presence of or calphostin C (CAL) (5 3 1027 m). Data are expressed as the percentage of dpHi/dt compared with those observed in ALDO-
untreated VSMCs without CAL (control). The number of experiments done on CAL-treated VSMCs is 6. (C) VSMCs were exposed to control
MEM or ALDO (1026 m)-supplemented MEM for 3 or 24 hours with or without 24 hours of pre-exposure with phorbol 12-myristate 13-acetate
(PMA; 1027 m). Data are expressed as the percentage of dpHi/dt compared with those observed in ALDO-untreated VSMCs without PMA
(control). The number of experiments done on PMA-treated VSMCs is 6. (D) VSMCs were exposed to control MEM or PMA (1027 m)-supplemented
MEM for 3 hours. Data are expressed as the percentage of dpHi/dt compared with those observed in control MEM. The number of experiments
done on PMA-treated VSMCs is 5.
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Fig. 10. Long-term effect of ALDO on steady-state NHE (NHE-1)
mRNA levels in VSMCs. VSMCs were exposed to control MEM or
ALDO (1026 m)-supplemented MEM for 24 hours. Five micrograms of
Poly (A)1 RNA from control and ALDO-treated VSMCs were size-
fractionated by 1% agarose-formaldehyde gel electrophoresis, trans-
ferred to nylon membranes, and hybridized to [32P]-labeled rat NHE-1
(upper panel) and GAPDH (lower panel) cDNA probes. The positions
of the 28S and 18S markers are shown on the right of the figure. Data
are representative of 4 separate experiments that gave similar results.
et al reported in VSMCs that ALDO rapidly increases
(4 min) NHE activity in VSMCs [8]. They also reportedFig. 9. Effects of cytoskeleton disruptors, colchicine (COL) or cytocha-
that ALDO rapidly increases (3 to 5 min) [Ca21]i inlasin B (CYTO) on the short-term ALDO-induced increase in NHE
activity in VSMCs. VSMCs were exposed to control MEM or ALDO VSMCs [10]. We did not observe the very rapid effects
(1026 m)-supplemented MEM for 3 hours in the absence or presence
reported by Christ et al [8, 10], and we cannot definitivelyof COL (1024 m) or CYTO (1024 m). Data are expressed as the percent-
explain this discrepancy at the present time. One possibleage of dpHi/dt compared with those observed in ALDO-untreated
VSMCs without COL or CYTO (control). There were 6 experiments explanation is the difference of the cell growth conditions
on COL- or CYTO-treated VSMCs.
between the two studies: we used confluent VSMCs,
whereas they used subconfluent VSMCs [10]. We specu-
late that NHE activity in confluent VSMCs could be
Short-term activation of NHE by aldosterone less sensitive to ALDO than in subconfluent VSMCs,
because confluent VSMCs are relatively contact-inhib-Previous studies have shown that in VSMCs, ALDO
ited. Wehling et al have shown that after treatment ofrapidly increases [Ca21]i [11, 12], pHi [9], and EIPA-
VSMCs with ALDO, a transient minor acidification issensitive 22Na uptake [8]. However, it has not yet been
followed by a continuous cell alkalinization, reaching aestablished whether these ALDO effects are nongenomic
new plateau about 0.1 pH unit above the initial baselineeffects. In the present study, the short-term stimulatory
within six to eight minutes [9]. They conclude that theeffect of ALDO on NHE activity was not affected by
cell alkalinization is due to increased NHE activity in-inhibitors of transcription (ACD) and of translation
duced by ALDO, since this is inhibited by addition of(CHX) as well as by antagonists of MR (SPR) and of
the NHE inhibitor, HOE694. However, it is not knownGR (RU). Therefore, the short-term effect of ALDO is
whether the cell alkalinization is actually influenced byrelated to a nongenomic effect and is not mediated
NHE activity, since they did not estimate intracellularthrough classic intracellular steroid receptors. ALDO
buffering capacity.has been reported to produce a rapid effect on intracellu-
As second messengers responsible for the rapid nonge-lar electrolyte concentrations, cell volume, and activity
nomic ALDO effect, stimulation of IP3 and DAG, andof NHE in human mononuclear leukocytes [6]. Similar
activation of PLC, have been shown in VSMCs [8, 9].nongenomic ALDO effects have been reported in
Furthermore, rapid rises in [Ca21]i and translocation ofMDCK cells [7]. In these cells [6, 7], the nongenomic
stimulation of NHE occurred within 15 minutes. Christ PKC a isoform from cytosol to plasma membrane have
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been reported in ALDO-treated VSMCs [10, 11]. In in various cell types [34, 38, 39]. Bloch et al reported
that angiotensin II stimulates NHE in the rabbit proximalhuman mononuclear leukocytes and VSMCs, it has been
tubule and that this stimulation is inhibited by a microtu-proposed that ALDO activates PLC, which may induce
bule disrupting agent, COL [14], suggesting the possibil-a hydrolitic breakdown of phosphoinositides into IP3 and
ity that microtubule may be involved in the angiotensinDAG. Subsequently, IP3 causes a release of [Ca21]i from
II-induced increase in NHE activity. Watson et al haveintracellular stores, and DAG activates PKC. However,
shown in Caco-2 cells that cytochalasin, but not COL,it has not yet been demonstrated whether PKC activation
inhibited the reduction of NHE which occurred due tois actually responsible for the rapid nongenomic ALDO
four hours of serum deprivation, but did not inhibit resto-effect on NHE activity in VSMCs. Although PKC a
ration of NHE when the cells were re-exposed to serumisoform translocation from cytosol to plasma membrane
for a further four hours [15]. These findings suggest thatin ALDO-treated VSMCs has been reported [10], it is
F-actin may regulate either the endocytic retrieval ofnot known whether this actually corresponds to activa-
NHE from the plasma membrane or the exocytic inser-tion of PKC. Furthermore, assays based on the measure-
tion of NHE into the plasma membrane. In addition,ment of apparent PKC translocation can be susceptible
treatment with COL has been shown to inhibit exocyticto homogenization artifacts. In particular, the affinity of
insertions of H1 pump into apical membrane of renalthe plasma membrane for PKC may differ markedly,
proximal tubular cells [38]. In renal cortical collectingdepending on whether the enzyme is activated by hor-
duct cell line (RCCT-28A), Schwiebert et al demon-mones, phorbol esters, membrane-permeable diglycer-
strated that hypotonic cell swelling activates the 305-pSides, or endogenous DAG [36]. Therefore, the present
Cl2 channel and that this channel contributes to regula-studies further extend the studies of Christ et al [10] to
tory volume decrease (RVD) by a mechanism involvingdetermine the role of PKC in the nongenomic ALDO
membrane stretch and disruption of F-actin [39]. PKCeffect on NHE activity in VSMCs. We demonstrate that
may be involved in the swelling-induced depolymeriza-two dissimilar inhibitors of PKC activity (ST and CAL)
tion of F-actin, since treatment with the specific PKCor prior down-regulation of PKC activity by 24 hours of
inhibitor, CAL, prevented swelling-induced depolymeri-pre-exposure to PMA prevented the short-term stimula-
zation on F-actin and inhibited the RVD [34]. By contrast,tory effect of ALDO on NHE activity. The short-term
1-oleoyl-2-acetylglycerol, a permeable analog of DAG,effect of ALDO on NHE activity was mimicked by expo-
fragmented F-actin and activated the 305-pS Cl2 channelsure of VSMCs to PMA for 3 hours. We also found
in cells bathed in an isotonic solution [34]. Therefore,that ALDO transiently activates PKC in VSMCs. Taken
RVD and Cl2 channel in RCCT-28 cells is regulated bytogether, we conclude that the nongenomic ALDO effect
a complex signaling pathway involving F-actin and PKC.
on NHE activity in VSMCs is mediated through PKC Sardet et al reported, in hamster fibroblasts and A431
activation. In MDCK cells, it has been postulated that human epidermoid cells, that rapid activation of the
ALDO may activate plasma membrane H1 conductance NHE by mitogens is associated with increased phosphor-
through G-protein-dependent stimulation of PKC [37]. ylation of the NHE or a closely associated molecule [40,
The mechanisms whereby PKC activation induced by 41]. Many experiments suggest that PKC is one of the
ALDO regulates NHE in VSMCs are not yet clear. Sev- kinases responsible for this phosphorylation in VSMCs
eral mechanisms could be proposed for the rapid PKC- [19, 30]. Therefore, it is also possible that PKC could
dependent activation of NHE in VSMCs. In the present phosphorylate the regulatory protein of NHE or the
study we demonstrated that the disrupting agents of mi- NHE itself directly [19, 30, 40, 41], and subsequently
crotubule (COL) and of F-actin (CYTO) inhibit the short- activate NHE. Finally, direct PKC activation by PMA
term stimulatory effect of ALDO on NHE activity in has been shown to increase NHE activity by causing an
VSMCs. Since either COL or CYTO did not affect the alkaline shift in the pHi dependence of the antiport in
basal NHE activity in control VSMCs, the data indicate rat thymic lymphocytes [42, 43]. This could occur via a
that the short-term exposure of VSMCs to ALDO acti- PKC-dependent alkaline shift in the pHi responsiveness
vates COL- and CYTO-sensitive processes, which acti- of an allosteric modifier site on the cytoplasmic surface
vate NHE. However, it is presently unclear whether of the cell membrane [43, 44]. Therefore, there are nu-
NHE itself and/or PKC is shuttled to the plasma mem- merous potential mechanisms whereby ALDO-induced
brane to stimulate NHE in ALDO-treated VSMCs. There- PKC activation could promote an acute increase in NHE
fore, we propose that PKC activation could promote the activity in VSMCs. Further studies will be required to
exocytic insertion into the plasma membrane of NHE define the mechanisms for the PKC-dependent increase
previously stored in the cytoplasm. Such a “shuttle” pro- in NHE activity in VSMCs.
cess has been demonstrated for the angiotensin II-
Long-term activation of NHE by aldosteroneinduced increase in NHE activity in the renal proximal
tubule [14], serum deprivation-induced decrease in NHE In contrast to the short-term ALDO effect, the long-
term stimulatory effect of ALDO on NHE activity wasactivity in Caco-2 cells [15], and many other transporters
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inhibited by inhibitors of transcription (ACD) and of CA) induces changes in vascular reactivity to vasocon-
strictors, which initiate the development of systemic vas-translation (CHX). The long-term effect of ALDO on
NHE activity is associated with a significant increase in cular resistance in bilaterally nephrectomized dogs and
rats [51], and in unilateral nephrectomized pigs [52]. ANHE-1 mRNA levels. Therefore, the long-term effect
of ALDO is related to a genomic effect. Furthermore, similar finding was also reported for dogs after 16 days of
parenteral administration of ALDO [53]. Furthermore,our observation that the long-term effect of ALDO was
inhibited by the MR antagonist (SPR) indicates that the there is some evidence of membrane alterations in exper-
imental and human hypertension with mineralocorticoideffect of ALDO occurs through MR. However, the GR
antagonist RU also inhibited the long-term ALDO ef- excess. Jones has shown increased membrane cation
transport in VSMCs from DOCA-treated rats [54].fect. The concentration of ALDO used in the present
experiment (1026 m) is so high that ALDO may bind to Koren, Postnov and Postnov reported that red blood
cell NHE activity is enhanced in patients with primaryboth MR and GR, since ALDO also binds to the type
II GR in cultured VSMCs [45]. It is also possible that aldosteronism [47]. Taken together with these previous
reports and our findings, enhanced NHE activity inRU and/or some of its metabolites may be involved in
mineralocorticoid antagonist activity in VSMCs, since VSMCs could play an important role in the pathogenesis
of mineralocorticoid-induced hypertension.this drug exhibits “anti-mineralocorticoid” activity in hu-
mans [46]. Muto et al also reported in cultured VSMCs In conclusion, we clearly demonstrate that ALDO ac-
tivates NHE in VSMCs by nongenomic and genomicfrom rat aortae that ALDO (1026 m) increased Na,K-
ATPase b1 mRNA levels and that the ALDO-mediated mechanisms.
increase in b1 mRNA levels was inhibited by antagonists
of MR (SPR) and of GR (RU) [16]. ACKNOWLEDGMENTS
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Williams and Howard reported that the long-term expo- aldosterone; ATP, adenosine 59-triphosphate; BCECF-AM, 2979-bis
(carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester; bI, intra-sure of VSMCs to high glucose activates NHE, and that
cellular buffering capacity; BSA, bovine serum albumin; [Ca21]i, freethe high glucose-induced activation of NHE is mediated intracellular Ca21 concentration; CAL, calphostin C; CHX, cyclohexi-
via a PKC-dependent process [32]. Horie et al also dem- mide; COL, colchicine; CYTO, cytochalasin B; DAG, diacylglycerol;
DOCA, deoxycorticosterone acetate; EDTA, ethylenediaminetetra-onstrated in cultured proximal tubule cells that a chronic
acetatic acid; EGTA, egtazic acid; EIPA, ethylisopropylamiloride;increase in both NHE activity and mRNA expression is FBS, fetal bovine serum; GADPH, glyceraldehyde-3-phosphate dehy-
due to long-term phorbol ester-mediated PKC activation drogenase; GR, glucocorticoid receptor; IP3, inositol 1,4,5-trisphos-
phate; MDCK, Madin-Darby canine kidney; MEM, Eagle’s minimal[48]. PKC has been shown to regulate the expression of
essential medium; MR, mineralocorticoid receptor; NHE, Na1/H1 ex-numerous different genes. These genes usually express
change; NMDG, N-methyl-d-glucamine; pHi, intracellular pH; PKC,
“PKC responsive elements,” that is, various consensus se- protein kinase C; PMA, phorbol 12-myristate 13-acetate; RU,
RU38486; RVD, regulatory volume decrease; SPR, spironolactone;quences in the 59 flanking region of the gene that mediate
SSC, standard saline citrate; ST, staurosporine A; VSMCs, vascularPKC-responsive regulation of gene expression [49, 50].
smooth muscle cells.
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